Cardiovascular safety of methylphenidate – #ADHD

Originally posted 2016-06-20 16:09:52.


Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neuropsychiatric condition, characterised by age-inappropriate, pervasive and impairing levels of inattention and/or hyperactivity-impulsivity (American Psychiatric Association, 2013).

Pharmacological treatment is currently considered as an important component of the multimodal treatment of ADHD. Medications are recommended as the first treatment option in several guidelines/practice parameters (e.g., Pliszka S, 2007), at least for severe cases (NICE 2008, Taylor E. et al 2004), or as a treatment strategy for patients who did not respond to non-pharmacological interventions (NICE 2008).

Esta entrada fue publicada en Sin categoría y etiquetada . Guarda el enlace permanente.

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *